Cargando…
Intravenous sildenafil for treatment of early pulmonary hypertension in preterm infants
Data is lacking on the effect of continuous intravenous sildenafil treatment in preterm infants with early pulmonary hypertension (PH), especially in very low birth weight (VLBW) infants. Preterm infants (< 37 weeks of gestational age) with intravenous sildenafil treatment and diagnosis of PH bet...
Autores principales: | Schroeder, Lukas, Monno, Paulina, Strizek, Brigitte, Dresbach, Till, Mueller, Andreas, Kipfmueller, Florian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10209068/ https://www.ncbi.nlm.nih.gov/pubmed/37225769 http://dx.doi.org/10.1038/s41598-023-35387-y |
Ejemplares similares
-
Evaluation of levosimendan as treatment option in a large case-series of preterm infants with cardiac dysfunction and pulmonary hypertension
por: Schroeder, Lukas, et al.
Publicado: (2023) -
Heart rate control with landiolol hydrochloride in infants with ventricular dysfunction and pulmonary hypertension
por: Schroeder, Lukas, et al.
Publicado: (2022) -
Circulating microRNAs are associated with Pulmonary Hypertension and Development of Chronic Lung Disease in Congenital Diaphragmatic Hernia
por: Herrera-Rivero, Marisol, et al.
Publicado: (2018) -
Population pharmacokinetic analysis of sildenafil in term and preterm infants with pulmonary arterial hypertension
por: Rhee, Su-jin, et al.
Publicado: (2022) -
Feasibility of bedside portable MRI in neonates and children during ECLS
por: Sabir, Hemmen, et al.
Publicado: (2023)